Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
| Generic Name | Brand Name |
|---|---|
| capecitabine | Xeloda |
Capecitabine belongs to a class of drugs called antimetabolites. It interferes with the growth of cancer cells. Capecitabine is available as tablets that are taken by mouth (oral).
Capecitabine is used to treat cancer, such as metastatic breast cancer and colorectal cancer.
Capecitabine is an effective antitumor drug for many people. But the type and extent of a cancer determines how effectively this drug slows or stops the growth of cancer cells in the body. One study shows that treating stage III metastatic colon cancer with capecitabine after surgery is at least as effective as treating with fluorouracil plus leucovorin after surgery. People taking capecitabine had later and less severe side effects.1
Side effects of capecitabine can be severe.
Hand-foot syndrome is a problem for some people taking capecitabine. Your doctor will watch you closely and change how much medicine you are taking if you start to have a problem with your hands or feet.2
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Capecitabine should be administered only under the supervision of a medical oncologist.
When used in combination with blood-thinning drugs (anticoagulants), such as warfarin (Coumadin) or heparin, capecitabine can cause serious bleeding and death. Tell your doctor if you are taking warfarin or an other anticoagulant drug, including aspirin. If you have any unusual bleeding or bruising, call your doctor immediately.
You may not be able to become pregnant or father a child after taking this medicine. Discuss fertility with your doctor before starting treatment.
Capecitabine can cause birth defects. Do not use this drug if you are pregnant or wish to become pregnant or father a child while you are taking it.
Do not drink alcohol beverages while taking capecitabine.
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Citations
- Twelves C, et al. (2005). Capecitabine as adjuvant treatment for stage III colon cancer. New England Journal of Medicine, 352(26): 2696–2704.
- National Comprehensive Cancer Network (2010). Colon cancer. NCCN Clinical Practice Guidelines in Oncology, version 2. Available online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.
Last Revised: September 13, 2010
Author: Healthwise Staff
Medical Review: Kathleen Romito, MD - Family Medicine & Arvydas D. Vanagunas, MD - Gastroenterology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Steps @Sanfordhealth takes to plan for disasters http://t.co/Iy65PMivGG